UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 20, 2017 (March 16, 2017)
GLOBAL MEDICAL REIT INC.
(Exact name of registrant as specified in its charter)
| Maryland | 8091371022 | 46-4757266 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
4800 Montgomery Lane, Suite 450 Bethesda, MD 20814 |
||
| (Address of Principal Executive Offices) (Zip Code) |
(202) 524-6851
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 8.01. OTHER EVENTS.
Declaration of Dividend
On March 20, 2017, Global Medical REIT Inc. (the “Company”) announced the declaration of a cash dividend for the first quarter of 2017 of $0.20 per share of common stock to stockholders of record as of March 27, 2017, to be paid on or about April 10, 2017.
ITEM 7.01 REGULATION FD DISCLOSURE
The Company issued a press release on March 20, 2017 announcing the dividend before this report was filed. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information in Exhibit 99.1 referenced in Item 9.01 below is being “furnished” and, as such, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed by the Company pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | Press release dated March 20, 2017 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GLOBAL MEDICAL REIT INC. | ||
| By: | /s/ Conn Flanigan | |
| Conn Flanigan | ||
| Secretary and General Counsel | ||
Dated: March 20, 2017
| 2 |